Literature DB >> 1819701

Quantitation by radioimmunoassay of PAF in human saliva.

S J Cooney1, M A Smal, B A Baldo.   

Abstract

Approximately 75% of the PAF present in saliva is recovered on extraction of whole saliva (0.8 vol) with chloroform/methanol/water (2:2:1, v/v/v). PAF levels, determined by our recently developed radioimmunoassay, in saliva extracts ranged from 0.5-21 ng/mL with 59% between 2-6 ng/mL. These figures, for apparently healthy subjects, are higher than previously reported levels obtained by platelet assays. The validity of our radioimmunoassay results was checked by isolating and quantitating the PAF fraction from whole saliva. In addition, when we examined our saliva samples by platelet aggregation, low levels of PAF, comparable with the values found in the literature, were detected. Investigations revealed the presence of a substance(s) which inhibited PAF-induced platelet aggregation but which did not affect the radioimmunoassay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819701     DOI: 10.1007/BF02536518

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  19 in total

Review 1.  Platelet activating factor: a biologically active phosphoglyceride.

Authors:  D J Hanahan
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 2.  Platelet-activating factor as a mediator of allergic disease.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

3.  A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets.

Authors:  Y N Huo; J Ekholm; D J Hanahan
Journal:  Arch Biochem Biophys       Date:  1988-02-01       Impact factor: 4.013

4.  The presence of platelet-activating factor (PAF) in normal human mixed saliva.

Authors:  C P Cox; M L Wardlow; R Jorgensen; R S Farr
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

5.  Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.

Authors:  J Benveniste; R Roubin; M Chignard; E Jouvin-Marche; J P Le Couedic
Journal:  Agents Actions       Date:  1982-12

6.  Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus.

Authors:  R Nakayama; K Yasuda; K Saito
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

7.  Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver.

Authors:  M Miwa; C Hill; R Kumar; J Sugatani; M S Olson; D J Hanahan
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

8.  A specific, sensitive and high-capacity immunoassay for PAF.

Authors:  B A Baldo; M A Smal; A C McCaskill
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

9.  Inhibitor(s) of platelet-activating factor (PAF) in human saliva.

Authors:  M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

10.  Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets.

Authors:  E Coëffier; E Ninio; J P Le Couedic; M Chignard
Journal:  Br J Haematol       Date:  1986-04       Impact factor: 6.998

View more
  2 in total

1.  A specific, sensitive and high-capacity immunoassay for PAF.

Authors:  B A Baldo; M A Smal; A C McCaskill
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Inhibitor(s) of platelet-activating factor (PAF) in human saliva.

Authors:  M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.